Stockreport

Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress [Yahoo! Finance]

Ventyx Biosciences, Inc.  (VTYX) 
PDF Cash, cash equivalents and marketable securities of $302.6 million as of March 31, 2024 are expected to fund planned operations into at least the second half of 2026 [Read more]